YiChang prices HK1.67bn listing at mid point
YiChang HEC ChangJiang Pharmaceutical Co has priced its HK$1.67bn ($215.4m) IPO in the middle of the range, driven by price sensitive investors in the final book.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: